| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CRISPR-Cas Systems | 46 | 2025 | 369 | 8.870 |
Why?
|
| Gene Editing | 38 | 2026 | 331 | 8.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 18 | 2024 | 100 | 5.100 |
Why?
|
| Bacteriophages | 11 | 2020 | 65 | 2.990 |
Why?
|
| RNA | 13 | 2024 | 427 | 2.740 |
Why?
|
| CRISPR-Associated Proteins | 7 | 2024 | 32 | 2.470 |
Why?
|
| Neisseria meningitidis | 9 | 2019 | 76 | 2.440 |
Why?
|
| RNA, Small Interfering | 18 | 2011 | 990 | 2.180 |
Why?
|
| RNA Interference | 16 | 2011 | 647 | 2.010 |
Why?
|
| DNA | 13 | 2026 | 853 | 1.860 |
Why?
|
| RNA, Bacterial | 7 | 2014 | 73 | 1.780 |
Why?
|
| Viral Proteins | 6 | 2023 | 270 | 1.580 |
Why?
|
| Tyrosinemias | 3 | 2022 | 20 | 1.550 |
Why?
|
| Endonucleases | 8 | 2023 | 84 | 1.470 |
Why?
|
| Bacterial Proteins | 12 | 2020 | 741 | 1.470 |
Why?
|
| Viruses | 2 | 2023 | 82 | 1.340 |
Why?
|
| MicroRNAs | 10 | 2025 | 714 | 1.240 |
Why?
|
| Proteomics | 3 | 2018 | 299 | 1.220 |
Why?
|
| RNA-Induced Silencing Complex | 9 | 2009 | 72 | 1.210 |
Why?
|
| Genetic Engineering | 6 | 2026 | 114 | 1.180 |
Why?
|
| RNA-Directed DNA Polymerase | 4 | 2025 | 39 | 1.060 |
Why?
|
| Staphylococcus epidermidis | 3 | 2015 | 11 | 1.060 |
Why?
|
| RNA Splicing | 13 | 2012 | 173 | 1.050 |
Why?
|
| Dependovirus | 6 | 2025 | 760 | 1.010 |
Why?
|
| Adenine | 2 | 2024 | 48 | 0.960 |
Why?
|
| Animals | 50 | 2026 | 21465 | 0.940 |
Why?
|
| HEK293 Cells | 13 | 2025 | 617 | 0.900 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2010 | 85 | 0.870 |
Why?
|
| Genetic Loci | 3 | 2018 | 117 | 0.860 |
Why?
|
| Genome, Human | 5 | 2021 | 238 | 0.850 |
Why?
|
| Interspersed Repetitive Sequences | 2 | 2017 | 12 | 0.840 |
Why?
|
| DNA, Single-Stranded | 4 | 2022 | 109 | 0.840 |
Why?
|
| RNA, Double-Stranded | 6 | 2011 | 113 | 0.830 |
Why?
|
| Endodeoxyribonucleases | 3 | 2024 | 44 | 0.810 |
Why?
|
| Gene Silencing | 7 | 2022 | 436 | 0.800 |
Why?
|
| Drosophila Proteins | 9 | 2010 | 758 | 0.800 |
Why?
|
| Genetic Vectors | 7 | 2025 | 929 | 0.790 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2023 | 17 | 0.790 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2014 | 127 | 0.790 |
Why?
|
| Recombinational DNA Repair | 2 | 2026 | 29 | 0.750 |
Why?
|
| DNA, Bacterial | 3 | 2015 | 262 | 0.740 |
Why?
|
| Drosophila melanogaster | 8 | 2010 | 560 | 0.720 |
Why?
|
| Proprotein Convertase 9 | 2 | 2018 | 15 | 0.710 |
Why?
|
| Spliceosomes | 6 | 2008 | 44 | 0.710 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2014 | 573 | 0.700 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.700 |
Why?
|
| Mice | 23 | 2025 | 11174 | 0.700 |
Why?
|
| Drosophila | 5 | 2011 | 479 | 0.700 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2014 | 451 | 0.680 |
Why?
|
| Transformation, Bacterial | 2 | 2013 | 12 | 0.680 |
Why?
|
| Genome, Bacterial | 2 | 2018 | 67 | 0.640 |
Why?
|
| Base Sequence | 16 | 2022 | 1331 | 0.630 |
Why?
|
| Mutant Chimeric Proteins | 2 | 2018 | 6 | 0.620 |
Why?
|
| Models, Genetic | 6 | 2015 | 267 | 0.610 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 57 | 0.610 |
Why?
|
| Genome | 8 | 2026 | 286 | 0.590 |
Why?
|
| Archaea | 3 | 2020 | 10 | 0.590 |
Why?
|
| Ascorbate Peroxidases | 1 | 2018 | 1 | 0.580 |
Why?
|
| Bacteria | 4 | 2020 | 337 | 0.580 |
Why?
|
| RNA Helicases | 5 | 2006 | 99 | 0.570 |
Why?
|
| RNA Precursors | 8 | 2015 | 80 | 0.550 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 27 | 0.550 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 61 | 0.510 |
Why?
|
| Plasmids | 3 | 2018 | 294 | 0.510 |
Why?
|
| Humans | 50 | 2026 | 65646 | 0.500 |
Why?
|
| Ubiquitin | 2 | 2008 | 104 | 0.490 |
Why?
|
| RNA, Catalytic | 5 | 2001 | 21 | 0.480 |
Why?
|
| Marinomonas | 1 | 2016 | 1 | 0.480 |
Why?
|
| Inverted Repeat Sequences | 2 | 2013 | 14 | 0.470 |
Why?
|
| Ribonuclease III | 8 | 2013 | 86 | 0.470 |
Why?
|
| Genetic Therapy | 5 | 2026 | 852 | 0.460 |
Why?
|
| Liver | 2 | 2022 | 874 | 0.440 |
Why?
|
| Oligonucleotides | 4 | 2024 | 229 | 0.440 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 792 | 0.440 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2026 | 91 | 0.430 |
Why?
|
| Spores, Fungal | 1 | 2014 | 22 | 0.430 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2014 | 13 | 0.420 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2026 | 70 | 0.420 |
Why?
|
| Nucleotide Motifs | 3 | 2020 | 52 | 0.410 |
Why?
|
| RNA-Binding Proteins | 2 | 2011 | 446 | 0.410 |
Why?
|
| Publishing | 1 | 2015 | 95 | 0.400 |
Why?
|
| Escherichia coli Proteins | 2 | 2014 | 278 | 0.380 |
Why?
|
| Escherichia coli | 4 | 2019 | 717 | 0.380 |
Why?
|
| RNA, Small Nuclear | 4 | 2001 | 25 | 0.380 |
Why?
|
| RNA, Messenger | 9 | 2014 | 1581 | 0.370 |
Why?
|
| Hepatoblastoma | 2 | 2022 | 10 | 0.350 |
Why?
|
| Meiosis | 1 | 2012 | 80 | 0.350 |
Why?
|
| DNA Repair | 2 | 2025 | 263 | 0.340 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 105 | 0.340 |
Why?
|
| Metals | 4 | 2001 | 65 | 0.340 |
Why?
|
| Streptococcus thermophilus | 1 | 2010 | 3 | 0.330 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2015 | 185 | 0.330 |
Why?
|
| Spermatogenesis | 1 | 2011 | 76 | 0.320 |
Why?
|
| DNA, Viral | 1 | 2010 | 232 | 0.300 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 1979 | 0.300 |
Why?
|
| Genomics | 2 | 2026 | 386 | 0.300 |
Why?
|
| Deoxyribonucleases | 1 | 2009 | 32 | 0.290 |
Why?
|
| Conjugation, Genetic | 1 | 2008 | 16 | 0.290 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2008 | 14 | 0.290 |
Why?
|
| Templates, Genetic | 3 | 2026 | 24 | 0.290 |
Why?
|
| Substrate Specificity | 4 | 2018 | 342 | 0.280 |
Why?
|
| Protein Domains | 5 | 2025 | 155 | 0.280 |
Why?
|
| Introns | 4 | 2012 | 114 | 0.280 |
Why?
|
| Zebrafish | 2 | 2022 | 374 | 0.270 |
Why?
|
| Nucleic Acid Conformation | 9 | 2015 | 241 | 0.270 |
Why?
|
| K562 Cells | 4 | 2022 | 59 | 0.270 |
Why?
|
| Endoribonucleases | 2 | 2005 | 57 | 0.260 |
Why?
|
| Deoxyribonuclease I | 2 | 2022 | 41 | 0.250 |
Why?
|
| Binding Sites | 9 | 2019 | 917 | 0.250 |
Why?
|
| Adenosine Triphosphate | 2 | 2005 | 301 | 0.250 |
Why?
|
| Sulfur | 5 | 2000 | 16 | 0.240 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 1573 | 0.230 |
Why?
|
| Evolution, Molecular | 5 | 2018 | 351 | 0.230 |
Why?
|
| Mutagenesis, Insertional | 1 | 2026 | 94 | 0.230 |
Why?
|
| RNA Cleavage | 1 | 2025 | 19 | 0.220 |
Why?
|
| Models, Molecular | 4 | 2020 | 1155 | 0.220 |
Why?
|
| Archaeal Proteins | 1 | 2004 | 6 | 0.220 |
Why?
|
| Mutation | 8 | 2026 | 2670 | 0.220 |
Why?
|
| Deoxyribonucleotides | 1 | 2024 | 13 | 0.210 |
Why?
|
| Exons | 6 | 2023 | 208 | 0.210 |
Why?
|
| Nitrogen | 1 | 2004 | 21 | 0.210 |
Why?
|
| Peptide Initiation Factors | 1 | 2004 | 37 | 0.210 |
Why?
|
| Precision Medicine | 1 | 2026 | 134 | 0.210 |
Why?
|
| Amino Acid Motifs | 2 | 2020 | 156 | 0.210 |
Why?
|
| Liver Diseases | 1 | 2025 | 157 | 0.200 |
Why?
|
| Cations, Divalent | 3 | 2001 | 25 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2025 | 183 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 689 | 0.200 |
Why?
|
| Ribonucleoproteins | 3 | 2022 | 116 | 0.200 |
Why?
|
| DNA Cleavage | 2 | 2020 | 17 | 0.200 |
Why?
|
| Databases, Genetic | 1 | 2024 | 91 | 0.200 |
Why?
|
| Tissue Distribution | 1 | 2024 | 292 | 0.200 |
Why?
|
| Biotechnology | 1 | 2023 | 38 | 0.190 |
Why?
|
| Catalysis | 7 | 2019 | 164 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 441 | 0.170 |
Why?
|
| Multigene Family | 2 | 2020 | 106 | 0.170 |
Why?
|
| Sequence Deletion | 2 | 2018 | 115 | 0.170 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 46 | 0.170 |
Why?
|
| HeLa Cells | 7 | 2021 | 541 | 0.170 |
Why?
|
| Virulence | 2 | 2013 | 199 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 3501 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 154 | 0.170 |
Why?
|
| Cells | 1 | 2021 | 32 | 0.160 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 90 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2022 | 215 | 0.160 |
Why?
|
| Thermogenesis | 1 | 2021 | 128 | 0.160 |
Why?
|
| DNA, Intergenic | 2 | 2010 | 24 | 0.160 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 117 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2006 | 672 | 0.160 |
Why?
|
| Cell Line | 5 | 2025 | 2029 | 0.160 |
Why?
|
| Biological Coevolution | 1 | 2020 | 1 | 0.160 |
Why?
|
| Lung | 2 | 2022 | 969 | 0.160 |
Why?
|
| Frontotemporal Dementia | 1 | 2022 | 158 | 0.160 |
Why?
|
| Fibroblasts | 1 | 2022 | 423 | 0.160 |
Why?
|
| Dinucleoside Phosphates | 1 | 2020 | 32 | 0.160 |
Why?
|
| Cross-Linking Reagents | 2 | 2005 | 119 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2021 | 135 | 0.150 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 3 | 2008 | 8 | 0.150 |
Why?
|
| Argonaute Proteins | 3 | 2005 | 154 | 0.150 |
Why?
|
| Metagenome | 1 | 2019 | 18 | 0.150 |
Why?
|
| Thionucleotides | 1 | 1999 | 39 | 0.150 |
Why?
|
| Hepatocytes | 1 | 2021 | 226 | 0.150 |
Why?
|
| Protein Multimerization | 1 | 2020 | 181 | 0.150 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2025 | 89 | 0.150 |
Why?
|
| Neisseriaceae | 1 | 2018 | 2 | 0.150 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2018 | 3 | 0.150 |
Why?
|
| RNA, Fungal | 1 | 1999 | 44 | 0.140 |
Why?
|
| 4-Hydroxyphenylpyruvate Dioxygenase | 1 | 2018 | 2 | 0.140 |
Why?
|
| Zygote | 1 | 2018 | 45 | 0.140 |
Why?
|
| Embryo Transfer | 1 | 2018 | 24 | 0.140 |
Why?
|
| Protein Binding | 2 | 2020 | 1633 | 0.140 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 129 | 0.140 |
Why?
|
| Transgenes | 1 | 2019 | 207 | 0.140 |
Why?
|
| Oxidoreductases | 1 | 2018 | 61 | 0.140 |
Why?
|
| Multifunctional Enzymes | 1 | 2018 | 19 | 0.140 |
Why?
|
| Herpesviridae | 1 | 2018 | 15 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1634 | 0.140 |
Why?
|
| Base Pairing | 2 | 2010 | 42 | 0.140 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 385 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 308 | 0.130 |
Why?
|
| Thiouridine | 2 | 1994 | 2 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2018 | 85 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 369 | 0.130 |
Why?
|
| RNA, Small Untranslated | 2 | 2014 | 19 | 0.130 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2327 | 0.130 |
Why?
|
| Ribonucleoprotein, U4-U6 Small Nuclear | 2 | 2008 | 7 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2022 | 517 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 297 | 0.130 |
Why?
|
| Proteome | 1 | 2018 | 153 | 0.130 |
Why?
|
| Capsid Proteins | 1 | 2018 | 107 | 0.130 |
Why?
|
| Models, Biological | 3 | 2009 | 1193 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 296 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 503 | 0.120 |
Why?
|
| Conserved Sequence | 3 | 2010 | 173 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 417 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2022 | 1559 | 0.120 |
Why?
|
| Thermodynamics | 3 | 2006 | 196 | 0.120 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 708 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2014 | 84 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2020 | 1588 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 92 | 0.100 |
Why?
|
| Chromatin | 3 | 2022 | 643 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2013 | 103 | 0.100 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 183 | 0.100 |
Why?
|
| Obesity | 1 | 2021 | 1277 | 0.100 |
Why?
|
| Meningococcal Infections | 1 | 2013 | 20 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2013 | 111 | 0.100 |
Why?
|
| Models, Chemical | 3 | 2005 | 137 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 72 | 0.090 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 115 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2010 | 2193 | 0.090 |
Why?
|
| Adenoviridae | 4 | 2015 | 132 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 909 | 0.090 |
Why?
|
| Catalytic Domain | 2 | 2004 | 198 | 0.090 |
Why?
|
| Ubiquitination | 2 | 2009 | 124 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.080 |
Why?
|
| RNA Editing | 2 | 2026 | 27 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 279 | 0.080 |
Why?
|
| Neoplasms | 1 | 2021 | 1376 | 0.080 |
Why?
|
| Streptococcus | 2 | 2020 | 19 | 0.080 |
Why?
|
| RNA, Archaeal | 1 | 2010 | 2 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 52 | 0.080 |
Why?
|
| Testis | 1 | 2011 | 160 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2010 | 267 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 141 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 91 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2009 | 85 | 0.070 |
Why?
|
| Staphylococcus Phages | 1 | 2008 | 1 | 0.070 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 105 | 0.070 |
Why?
|
| Male | 4 | 2021 | 31295 | 0.070 |
Why?
|
| Female | 3 | 2021 | 34309 | 0.070 |
Why?
|
| Transcriptome | 1 | 2012 | 405 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 797 | 0.070 |
Why?
|
| Sulfanilic Acids | 1 | 2008 | 1 | 0.070 |
Why?
|
| Immunity | 1 | 2009 | 107 | 0.070 |
Why?
|
| Endosomes | 1 | 2009 | 180 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 363 | 0.070 |
Why?
|
| Quinolines | 1 | 2008 | 47 | 0.070 |
Why?
|
| Proteins | 2 | 2009 | 764 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2008 | 87 | 0.070 |
Why?
|
| Mammals | 2 | 2023 | 222 | 0.070 |
Why?
|
| Oocytes | 1 | 2008 | 202 | 0.060 |
Why?
|
| Molecular Weight | 2 | 2004 | 194 | 0.060 |
Why?
|
| COP9 Signalosome Complex | 1 | 2006 | 2 | 0.060 |
Why?
|
| DNA End-Joining Repair | 1 | 2026 | 26 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2006 | 20 | 0.060 |
Why?
|
| Ovum | 1 | 2006 | 63 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1389 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 145 | 0.060 |
Why?
|
| Eukaryotic Cells | 1 | 2005 | 57 | 0.050 |
Why?
|
| Pyrococcus furiosus | 1 | 2004 | 1 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 333 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2011 | 829 | 0.050 |
Why?
|
| Moloney murine leukemia virus | 1 | 2024 | 17 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2004 | 15 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2005 | 132 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 46 | 0.050 |
Why?
|
| Hydroxyl Radical | 1 | 2004 | 8 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 156 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2004 | 52 | 0.050 |
Why?
|
| Eye Abnormalities | 1 | 2004 | 21 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2004 | 78 | 0.050 |
Why?
|
| Encyclopedias as Topic | 1 | 2024 | 5 | 0.050 |
Why?
|
| Point Mutation | 1 | 2004 | 168 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 162 | 0.050 |
Why?
|
| RNA Stability | 1 | 2004 | 104 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 53 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 278 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 708 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2004 | 413 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 458 | 0.050 |
Why?
|
| DNA Damage | 1 | 2025 | 298 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 399 | 0.050 |
Why?
|
| Dipeptides | 1 | 2022 | 69 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2022 | 59 | 0.050 |
Why?
|
| Trachea | 1 | 2022 | 83 | 0.040 |
Why?
|
| Biotinylation | 1 | 2022 | 36 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 1291 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2022 | 30 | 0.040 |
Why?
|
| Biotin | 1 | 2022 | 54 | 0.040 |
Why?
|
| Adipocytes, White | 1 | 2021 | 27 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 30 | 0.040 |
Why?
|
| C9orf72 Protein | 1 | 2022 | 115 | 0.040 |
Why?
|
| Subcutaneous Fat | 1 | 2021 | 50 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2022 | 184 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2022 | 257 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2022 | 219 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2021 | 115 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 195 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 181 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 96 | 0.040 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2000 | 7 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 225 | 0.040 |
Why?
|
| Nucleotides | 1 | 2000 | 48 | 0.040 |
Why?
|
| Neisseria | 1 | 2019 | 4 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 455 | 0.040 |
Why?
|
| Edetic Acid | 1 | 1999 | 24 | 0.040 |
Why?
|
| Chelating Agents | 1 | 1999 | 49 | 0.040 |
Why?
|
| Electrophoresis | 1 | 1999 | 16 | 0.040 |
Why?
|
| Allosteric Site | 1 | 1999 | 31 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 588 | 0.040 |
Why?
|
| Transfection | 1 | 2021 | 700 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 1999 | 71 | 0.040 |
Why?
|
| Magnesium | 1 | 1999 | 54 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2000 | 93 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2018 | 109 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 355 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2019 | 146 | 0.030 |
Why?
|
| Protein Stability | 1 | 2018 | 96 | 0.030 |
Why?
|
| Magnesium Chloride | 1 | 1997 | 6 | 0.030 |
Why?
|
| Manganese Compounds | 1 | 1997 | 8 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2018 | 260 | 0.030 |
Why?
|
| Chlorides | 1 | 1997 | 33 | 0.030 |
Why?
|
| RNA, Viral | 2 | 2000 | 266 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 100 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 300 | 0.030 |
Why?
|
| Brain | 1 | 2025 | 1625 | 0.030 |
Why?
|
| Protein Folding | 1 | 2018 | 268 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 351 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 242 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 140 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1715 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 718 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2004 | 3164 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2013 | 77 | 0.020 |
Why?
|
| RNA, Transfer, Ser | 1 | 1992 | 2 | 0.020 |
Why?
|
| Hepatitis, Chronic | 1 | 1992 | 6 | 0.020 |
Why?
|
| Selenocysteine | 1 | 1992 | 15 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 312 | 0.020 |
Why?
|
| Kinetics | 3 | 2000 | 757 | 0.020 |
Why?
|
| Ribonuclease H | 1 | 1992 | 19 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1992 | 35 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 37 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1992 | 77 | 0.020 |
Why?
|
| RNA Caps | 1 | 1992 | 17 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1992 | 152 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1992 | 185 | 0.020 |
Why?
|
| Phosphorylation | 1 | 1994 | 963 | 0.020 |
Why?
|
| Autoantigens | 1 | 1992 | 140 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 1992 | 239 | 0.020 |
Why?
|
| Hydrolysis | 2 | 2000 | 146 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 292 | 0.020 |
Why?
|
| United States | 1 | 2021 | 8166 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2000 | 16 | 0.010 |
Why?
|
| Manganese | 1 | 2000 | 20 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2000 | 127 | 0.010 |
Why?
|
| Ribonuclease P | 1 | 2000 | 2 | 0.010 |
Why?
|
| Oligoribonucleotides | 1 | 2000 | 16 | 0.010 |
Why?
|
| Bacillus subtilis | 1 | 2000 | 28 | 0.010 |
Why?
|
| Cytosine | 1 | 2000 | 31 | 0.010 |
Why?
|
| DNA Primers | 1 | 2000 | 302 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 634 | 0.010 |
Why?
|
| Nucleic Acid Precursors | 1 | 1993 | 2 | 0.010 |
Why?
|
| Globins | 1 | 1993 | 25 | 0.010 |
Why?
|
| Rabbits | 1 | 1993 | 342 | 0.010 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 1992 | 2 | 0.010 |
Why?
|
| Genes, Suppressor | 1 | 1992 | 7 | 0.010 |
Why?
|